GlassScriptPhysician profile
Regina Munoz
NPI 1033703731
$1,792.39
in general payments reported to CMS, 2019-2025
15 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.03 · 2022: $295 · 2023: $288 · 2024: $44.75 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $708.78 | 2025 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Impulse Dynamics (USA) INC. | $259.29 | 2023-2025 | Optimizer, Optimizer |
| Edwards Lifesciences Corporation | $142.77 | 2025 | Sapien 3 Ultra Resilia |
| Nuwellis, INC. | $132.45 | 2022 | |
| Novartis Pharmaceuticals Corporation | $122.44 | 2022-2023 | |
| Boston Scientific Corporation | $102.77 | 2025 | General - Therapies, Watchman Access System |
| Cvrx, INC. | $83.11 | 2022 | |
| Pfizer INC. | $58.22 | 2025 | |
| Atricure, INC. | $51.60 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Alnylam Pharmaceuticals INC. | $27.30 | 2023 | Onpattro |
| Hologic Sales and Service, LLC | $25.78 | 2024 | Aptima |
| Novo Nordisk INC | $24.65 | 2023 | Ozempic, Rybelsus |
| Gilead Sciences, INC. | $18.97 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.23 | 2023 | |
| Mylan Specialty L.P. | $17.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.